FDA Approves First mRNA Flu Vaccine for Adults 50 and Older
The U.S. Food and Drug Administration (FDA) has approved the first mRNA flu vaccine in the United States, giving adults ages 50 and up a new option for the 2026–2027…
The U.S. Food and Drug Administration (FDA) has approved the first mRNA flu vaccine in the United States, giving adults ages 50 and up a new option for the 2026–2027…